10
Participants
Start Date
May 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
July 31, 2008
Pegylated Alfa Interferon
Each patient will receive PEG-Intron administered subcutaneously one day per week of each 6 week cycle. The dose of PEG-Intron is determined based on the patient's weight and the dose level.
sunitinib
Patients will receive sunitinib orally as a single daily dose on Days 1-28 of each 42-day cycle. The dose will depend on the dose level.
erlotinib
Tarceva will be administered orally, 1-42 of each 42 day cycle. Dose will depend on dose level. Supplied as 150-mg, 100-mg and 25-mg strengths, white film-coated tablets for administration.
Baylor College of Medicine - Methodist Hospital, Houston
Collaborators (1)
Schering-Plough
INDUSTRY
The Methodist Hospital Research Institute
OTHER